Insider buying on Jul 28, 2026

On Jul 28, 2026, 32 insiders at 27 companies filed 46 purchases reported on Form 4, worth $133.5M in all, with a median purchase of $156.9K. The largest was Aghazadeh Behzad, Director, 10% owner of Scribe Therapeutics, Inc. (SCTX), who reported buying 2,333,333 shares worth $35.0M. Officers accounted for 8 purchases, directors who are not officers for 15, and 10% owners with no board or officer role for 22. Chief executives and chief financial officers filed 5 purchases: Semple Christopher James, Chief Executive Officer, Director of CIK 2035713; Meltzer Erez, Chief Executive Officer, Director of Nano-X Imaging Ltd. (NNOX); Ran Assaf, President and CEO, Director, 10% owner of Manhattan Bridge Capital, Inc (LOAN) among others. 8 companies showed cluster buying, two or more insiders buying within 7 days, among them SCTX (6 insiders), CIK 2035713 (5 insiders), BYRN (5 insiders), NNOX (3 insiders). For 14 insiders of 32, this was the first purchase of that company's stock on our record. That is fewer than the 63 purchases filed on Jul 27, 2026. A Form 4 is due within two business days of the trade, so most of these purchases were made earlier in the week. Code P also covers shares bought privately from the company, so one large figure can be a negotiated placement rather than buying on the exchange.